Hypersensitivity reaction to mizolastine: study of cross reactions.
A 26-year-old male suffering from acute rhinitis took the first dose of Zolistan (mizolastine, 10 mg), orally, and 15 minutes later he developed intense generalized pruritus, cutaneous rash, oropharyngeal pruritus, edema on his face, difficulty in swallowing, and mild dyspnea. He was treated with methylprednisolone and epinephrine and improved within 30 minutes. The patient had not taken mizolastine before and he has avoided it since the reaction. Cutaneous tests with Zolistan and its excipients proved negative. Simple-blind oral challenge tests with the excipients and then with Zolistan were positive only with Zolistan. In order to confirm the absence of cross-reactivity between mizolastine and other benzimidazoles, we tested omeprazole, domperidone and mebendazole, all of which yielded negative results. To our knowledge, this is the second case of immediate hypersensitivity to mizolastine documented to date. In our case, the clinical history, physical examination and provocation tests allow us to establish the diagnosis of hypersensitivity to mizolastine and exclude the cross reactivity with other benzimidazole derivatives.
Gonzalo-Garijo
M A
MA
Infanta Cristina University Hospital, Allergology Department, Badajoz, Spain. magonzalog@telefonica.net
Jiménez-Ferrera
G
G
Bobadilla-González
P
P
Cordobés-Durán
C
C
D000208:Acute Disease; D000328:Adult; D001562:Benzimidazoles / Q000009:adverse effects* / Q000276:immunology; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000276:immunology*; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D008297:Male; D012220:Rhinitis / Q000188:drug therapy
D001562:Benzimidazoles; D039563:Histamine H1 Antagonists, Non-Sedating; C076170:mizolastine